Pharma Industry News

February 21 2025 – Teva Pharma and Alvotech launch US biosimilar to J&J’s Stelara

Written by David Miller

Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
Device industry scrambles amid concern FDA layoffs will cause delays
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
Bluebird, at risk of default, agrees to take-private deal
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image: Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]